corporary

RX-EVOLUTION

Ceased
SIREN 538298035 VAT number FR93538298035

RX-EVOLUTION is a company registered under SIREN number 538298035, with its registered office in POUSSAN. Its main activity falls under the sector: Activities auxiliary to financial services and insurance activities. It is administratively ceased. Its reported revenue for the financial year ended in 2018 is 0 euros.

Sources: INSEE Sirene, INPI, comptes annuels.

Identity

Legal form
SAS, simplified joint-stock company
Activity
Security and commodity contracts brokerage (66.12Z)
Sector
Activities auxiliary to financial services and insurance activities
Headcount
Headcount unknown
Created
22 Nov 2011
Share capital
401,000.00 EUR
Registered with the trade register
23 Dec 2011
Financial year end
31/12
Establishments
1

Directors

Related companies

Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.

Establishments

Financial strength

Financial score

32 / 100 E

Confidence: low · computed on the financial year ended 31 Dec 2018

Equity to assets (19.7 %)
9.2 out of 30
EBITDA margin
data missing, component not taken into account
Liquidity (41.9 %)
0.7 out of 20
Debt (24.7 %)
11.0 out of 15
Revenue trend
data missing, component not taken into account

formula fin-1.0

Legal score

60 / 100 C

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
0.0 out of 20
Age (14.9 years)
20.0 out of 20
Accounts filed recently
0.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Revenue and net income by financial year
2016 2018

Revenue Net income

Financial year Revenue Change EBITDA Net income
31 Dec 2018 0 € — -1,519 € -1,519 €
31 Dec 2016 0 € first year on record -9,275 € -9,275 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Legal notices

  • Striking off 18 Aug 2020
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE MONTPELLIER

    BODACC B n 20200159, annonce n 525 · Proof of publication (PDF)

  • Filing of accounts 27 Jun 2019
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE MONTPELLIER
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2018

    BODACC C n 20190122, annonce n 3292 · Proof of publication (PDF)

Annual accounts as PDF →

Change history

  • officer_appointed (empty) → Commissaire aux comptes titulaire 9 Oct 2026
  • officer_appointed (empty) → Commissaire aux comptes suppleant 9 Oct 2026
  • officer_appointed (empty) → President de SAS 9 Oct 2026
  • capital (empty) → 401000.00 3 Oct 2026

Frequently asked questions about RX-EVOLUTION

What is the SIREN number of RX-EVOLUTION?
The SIREN number of RX-EVOLUTION is 538298035. Its intra-community VAT number is FR93538298035.
Where is the head office of RX-EVOLUTION?
Head office address: 13 RUE DU MALUZAN, 34560 POUSSAN.
When was RX-EVOLUTION founded?
RX-EVOLUTION was founded on 22 Nov 2011. It ceased trading on 18 Jun 2020.
What does RX-EVOLUTION do?
Its declared main activity is: Security and commodity contracts brokerage (NAF code 66.12Z).
Who runs RX-EVOLUTION?
The officers listed in the register are SCP CAZES - GODDYN (Commissaire aux comptes titulaire), Yann Joseph HETMANIAK (President de SAS).
What is the revenue of RX-EVOLUTION?
The latest published revenue is 0 €, for the 2018 financial year.
Is RX-EVOLUTION subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Report an error or request removal of this data